The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines - ScienceDirect
PER.C6® Cells for the Manufacture of Biopharmaceutical Proteins
PER.C6 Trademark - Registration Number 4584730 - Serial Number 85209126 :: Justia Trademarks
PAT for PER.C6® perfusion cultivation
PER.C6® Cells for the Manufacture of Biopharmaceutical Proteins
PPT - The single largest independent vaccine company in the world. PowerPoint Presentation - ID:2104179
Rebmab200, a Humanized Monoclonal Antibody Targeting the Sodium Phosphate Transporter NaPi2b Displays Strong Immune Mediated Cytotoxicity against Cancer: A Novel Reagent for Targeted Antibody Therapy of Cancer | PLOS ONE
Microbial Cleavage of C–F Bonds in Two C6 Per- and Polyfluorinated Compounds via Reductive Defluorination | Environmental Science & Technology
PPT - The single largest independent vaccine company in the world. PowerPoint Presentation - ID:2104179
Abortion Industry Contributes with the following tissues isolated from the aborted babies: MRC-5 lung tissue WI-38 lung tissue PER-C6 retinal tissue. - ppt download
Verificat
PAT for PER.C6® perfusion cultivation
293 and PER C6 Cell Lines Using AD5 - Life IssuesLife Issues
Effect of vector design on RCA free production in PER.C6 cell line. In... | Download Scientific Diagram
Per. C6® Cell HCP Standards A-F
PER.C6 Antigen Concentrate for F530 Kit
Ultrapure water: Meeting the cell culture challenge